14 days ago
REGN
AnalystsChris SchottChris Schott's Stock Forecasts
AnalystsChris Schott
Analyst Ranking
Top 8%
#433 out of 5557 analysts
Average Return
+13.7%
Win Rate
70%80 out of 114
Risk vs Reward
Poor
Good
Chris Schott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | +99.55% | $17.96 | $35.84 | 2025-05-12 - 2026-05-11 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +97.55% | $20.01 | $39.53 | 2025-10-03 - 2026-10-02 | Strong Buy |
Eli Lilly & CoLLY | +89.52% | $625.65 | $1,185.71 | 2025-08-08 - 2026-08-07 | Strong Buy |
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-28 - 2024-04-26 | Strong Buy |
Eli Lilly & CoLLY | +75.50% | $458.48 | $804.62 | 2023-07-28 - 2024-07-26 | Strong Buy |
Chris Schott Analyst Color
Get additional color on Chris Schott's coverage of popular stocks
14 days ago
LLY
a month ago
BIIB
a month ago
ABBV
a month ago
GILD
a month ago
REGN
a month ago
MRK
2 months ago
LLY
4 months ago
ABBV
4 months ago
LLY
9 months ago
LLY
a year ago
TEVA
a year ago
LLY
a year ago
TEVA
a year ago
ABBV
a year ago
GILD
a year ago
TEVA
a year ago
GILD
a year ago
LLY
a year ago
AMRX
a year ago
ABBV
a year ago
LLY
a year ago
IDXX
2 years ago
TEVA
2 years ago
AMRX
Chris Schott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Elanco Animal Health IncELAN | 7 | Strong Buy | $35.00 | +32.08% | Maintains | 5 days ago |
Viatris IncVTRS | 5 | Hold | $21.00 | +1.60% | Maintains | 7 days ago |
Amneal Pharmaceuticals IncAMRX | 6 | Strong Buy | $25.00 | +15.21% | Maintains | 10 days ago |
Amgen IncAMGN | 2 | Hold | $425.00 | -9.01% | Maintains | 10 days ago |
Regeneron Pharmaceuticals IncREGN | 12 | Strong Buy | $1,050.00 | +10.39% | Maintains | 14 days ago |
Merck & Co IncMRK | 8 | Strong Buy | $175.00 | +19.09% | Maintains | 14 days ago |
Gilead Sciences IncGILD | 10 | Strong Buy | $190.00 | +13.13% | Maintains | 14 days ago |
Eli Lilly & CoLLY | 21 | Strong Buy | $1,650.00 | +15.60% | Maintains | 14 days ago |
Idexx Laboratories IncIDXX | 10 | Strong Buy | $750.00 | +7.45% | Maintains | a month ago |
Teva Pharmaceutical Industries LtdTEVA | 12 | Strong Buy | $50.00 | +14.55% | Maintains | a month ago |
Biogen IncBIIB | 5 | Strong Buy | $300.00 | +19.77% | Upgrades | a month ago |
Pfizer IncPFE | 5 | Hold | $30.00 | +4.06% | Maintains | a month ago |
Abbvie IncABBV | 6 | Strong Buy | $300.00 | +1.88% | Maintains | a month ago |
Johnson & JohnsonJNJ | 2 | Hold | $285.00 | +0.52% | Maintains | 2 months ago |
Zoetis IncZTS | 5 | Strong Buy | $115.00 | +38.62% | Maintains | 3 months ago |
Royalty Pharma PLCRPRX | 6 | Strong Buy | $62.00 | -10.11% | Maintains | 3 months ago |
Bristol Myers Squibb CoBMY | 2 | Strong Buy | $73.00 | +17.14% | Maintains | 3 months ago |
Perrigo Co PLCPRGO | 7 | Hold | $18.00 | +11.25% | Maintains | a year ago |
Organon & CoOGN | 3 | Strong Sell | $12.00 | N/A | Maintains | a year ago |
Coherus Oncology IncCHRS | 2 | Hold | $11.00 | N/A | Maintains | 4 years ago |
Eqrx IncEQRX | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Heska CorpHSKA | 2 | Strong Buy | $150.00 | N/A | Maintains | 4 years ago |
Bausch Health Companies IncBHC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 6 years ago |
Kala Bio IncKALA | 4 | Strong Buy | $47,500.00 | N/A | Maintains | 6 years ago |
Therapeuticsmd IncTXMD | 2 | Hold | N/A | N/A | Downgrades | 6 years ago |
Endo International PLCENDPQ | 2 | Hold | $10.00 | N/A | Maintains | 8 years ago |
Pacira Biosciences IncPCRX | 2 | Hold | $50.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.